WELL Health Technologies Corp. (TSE:WELL) Receives Average Recommendation of “Buy” from Analysts

WELL Health Technologies Corp. (TSE:WELL) has received an average recommendation of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have issued a report on the stock in the last year is C$7.35.

A number of brokerages have issued reports on WELL. Canadian Imperial Bank of Commerce upgraded WELL Health Technologies from a “neutral” rating to an “outperform” rating in a report on Wednesday, December 3rd. Scotiabank decreased their price target on shares of WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating for the company in a report on Wednesday, February 4th.

WELL Health Technologies Price Performance

Shares of WELL stock opened at C$4.35 on Friday. The stock’s fifty day moving average is C$4.08 and its 200-day moving average is C$4.42. The company has a debt-to-equity ratio of 73.92, a quick ratio of 1.02 and a current ratio of 0.92. The stock has a market capitalization of C$1.10 billion, a PE ratio of -48.33, a PEG ratio of -1.93 and a beta of 0.85. WELL Health Technologies has a 52 week low of C$3.58 and a 52 week high of C$6.08.

About WELL Health Technologies

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.